Multidisciplinary Referral for Patients with cSCC and Care Transitions

Dr. Schoenfeld addresses when dermatologists should refer patients to radiation oncology and medical oncology. He emphasizes that early referral is critical for patients with high-risk features (large lesions, immunosuppression, or concern for nodal spread) to avoid delays in care and ensure clinical trial eligibility. At his institution, high-risk patients are presented to a multidisciplinary cutaneous oncology tumor board even before surgery, establishing a coordinated care pathway from the outset.

Dr. Schoenfeld identifies communication and transportation as key barriers for community clinicians, noting that early identification of high-risk patients allows time to connect them with lodging and referral resources. He stresses that ongoing communication, not just at initial referral but throughout surgery, radiation, and systemic therapy transitions, is essential to prevent patients from being lost between providers. Dr. Singh underscores that meeting patients where they are, not just treating the cancer, is central to equitable care.